Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Based on Chemotherapy for Advanced Non-small Cell Lung Squamous Carcinoma Patients：a Randomized Controlled,Open, Multicenter Clinical Study

NCT02513342 is registered in ClinicalTrials.gov with Nanjing NingQi Medicine Science and Technology Co., Ltd. as lead sponsor.

NCT NCT02513342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02513342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endostar First-line Treatment of Advanced Non-small Cell Lung Squamous Carcinoma Based on Chemotherapy for Advanced Non-small Cell Lung Squamous Carcinoma Patients：a Randomized Controlled,Open, Multicenter Clinical Study
Lead sponsor
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2015
Completion date
April 30, 2018
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced lung squamous carcinoma